Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CA Stock MarketDetailed Quotes
UnitedHealth CDR (CAD Hedged) (UNH)
- 16.980
- -0.090-0.53%
15min DelayMarket Closed May 1 16:00 ET
442.33BMarket Cap26.82P/E (TTM)
17.150High16.900Low107.55KVolume17.120Open17.070Prev Close1.83MTurnover18.79252wk High0.01%Turnover Ratio26.05BShares10.78652wk Low0.633EPS TTM15.29BFloat Cap28.993Historical High26.82P/E (Static)900.54MShs Float10.786Historical Low0.633EPS LYR1.47%Range %0.40Dividend TTM3.44P/B1Lot Size2.37%Div Yield TTM
UnitedHealth CDR (CAD Hedged) (UNH) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.62%19.7B | -53.23%1.11B | -57.37%5.95B | 6.55%7.19B | 376.92%5.46B | -16.73%24.2B | 145.62%2.37B | 102.04%13.95B | -38.85%6.75B | -92.99%1.14B |
| Net income from continuing operations | -15.98%12.81B | -96.23%218M | -59.36%2.54B | -19.20%3.57B | 630.22%6.47B | -34.14%15.24B | 1.92%5.78B | 3.64%6.26B | -21.85%4.42B | -121.15%-1.22B |
| Operating gains losses | -96.81%265M | 700.00%126M | 315.00%83M | -96.65%41M | -99.79%15M | --8.31B | ---21M | --20M | --1.23B | --7.09B |
| Depreciation and amortization | 6.39%4.36B | 7.30%1.12B | 5.57%1.1B | 6.27%1.08B | 6.42%1.06B | 3.20%4.1B | 6.88%1.04B | 3.38%1.04B | -0.10%1.02B | 2.78%997M |
| Remuneration paid in stock | -4.62%971M | -5.88%176M | -5.91%223M | -11.26%197M | 0.81%375M | -3.87%1.02B | -10.10%187M | -4.05%237M | -8.26%222M | 2.76%372M |
| Deferred tax | -491.89%-1.75B | -1,082.26%-733M | -851.61%-932M | 54.38%-151M | 337.04%64M | -20.82%-296M | -124.90%-62M | 1,133.33%124M | -120.67%-331M | 91.87%-27M |
| Other non cashItems | 122.70%763M | 125.41%699M | 94.11%-63M | -89.29%30M | -45.81%97M | -565.54%-3.36B | -516.82%-2.75B | -3,440.63%-1.07B | 275.00%280M | 159.42%179M |
| Change In working capital | 382.43%2.28B | 72.64%-495M | -59.20%2.99B | 2,753.85%2.42B | 57.87%-2.63B | -149.18%-808M | 84.74%-1.81B | 1,888.78%7.33B | -102.06%-91M | -165.82%-6.24B |
| -Change in receivables | 46.83%-764M | 60.93%-829M | -44.68%1.75B | -24.65%2.78B | 27.59%-4.46B | 53.85%-1.44B | -292.96%-2.12B | 213.89%3.16B | -18.03%3.69B | -43.10%-6.16B |
| -Change in payables and accrued expense | 50.81%7.49B | 16.68%1.73B | -30.01%1.87B | 246.83%1.51B | 29.82%2.39B | -29.04%4.97B | 87.23%1.48B | 18.65%2.67B | -232.79%-1.03B | -56.88%1.84B |
| -Change in other current assets | -11.26%-4.61B | -30.30%-1.5B | -184.91%-962M | 27.12%-1.6B | 71.77%-544M | -69.39%-4.14B | -1,239.53%-1.15B | 417.37%1.13B | -1,641.27%-2.19B | -2.77%-1.93B |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | 71.77%-544M | ---- | ---- | 417.37%1.13B | ---2.19B | ---1.93B |
| -Change in other working capital | 182.74%163M | 768.75%107M | -9.38%338M | 51.69%-272M | -211.11%-10M | -197.04%-197M | 99.87%-16M | -19.96%373M | -259.49%-563M | -99.92%9M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.62%19.7B | -53.23%1.11B | -57.37%5.95B | 6.55%7.19B | 376.92%5.46B | -16.73%24.2B | 145.62%2.37B | 102.04%13.95B | -38.85%6.75B | -92.99%1.14B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 57.69%-8.69B | -133.33%-2.61B | 19.34%-4.56B | 80.56%-1.44B | 98.83%-74M | -31.80%-20.53B | 5.73%-1.12B | -114.13%-5.65B | -918.82%-7.42B | 42.47%-6.34B |
| Net PPE purchase and sale | -3.52%-3.62B | -3.95%-948M | 10.19%-890M | -3.87%-886M | -20.86%-898M | -3.34%-3.5B | 4.90%-912M | -18.26%-991M | -2.90%-853M | 2.24%-743M |
| Net business purchase and sale | 66.37%-4.51B | 95.79%-73M | 57.17%-3.7B | -28.00%-32M | 76.65%-702M | -32.28%-13.41B | 0.74%-1.73B | -3,690.79%-8.64B | 92.54%-25M | 61.59%-3.01B |
| Net investment purchase and sale | -31.24%361M | 2.34%-1.3B | -84.08%330M | 115.43%110M | 147.36%1.22B | 129.54%525M | -223.67%-1.33B | 262.46%2.07B | -195.70%-713M | 121.22%492M |
| Net other investing changes | 77.93%-915M | -110.30%-294M | -115.50%-296M | 89.12%-634M | 110.02%309M | -1,407.27%-4.15B | 539.91%2.85B | 743.10%1.91B | -1,785.44%-5.83B | -2,580.87%-3.08B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 57.69%-8.69B | -133.33%-2.61B | 19.34%-4.56B | 80.56%-1.44B | 98.83%-74M | -31.80%-20.53B | 5.73%-1.12B | -114.13%-5.65B | -918.82%-7.42B | 42.47%-6.34B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -231.55%-11.64B | 87.64%-1.03B | -25.40%-2.77B | -564.46%-7.95B | -98.80%99M | 69.54%-3.51B | -16.57%-8.34B | 68.96%-2.21B | 88.56%-1.2B | -37.60%8.23B |
| Net issuance payments of debt | -95.05%726M | -272.17%-1.71B | -62.58%872M | -264.45%-2.35B | -65.58%3.91B | 242.52%14.66B | 70.66%-460M | 226.15%2.33B | 130.47%1.43B | -8.17%11.36B |
| Net common stock issuance | 34.05%-4.72B | 100.51%24M | 349.44%222M | -1,000.78%-2.32B | -2.09%-2.64B | -7.63%-7.15B | -299.41%-4.74B | 91.83%-89M | 109.50%258M | -56.16%-2.59B |
| Cash dividends paid | -5.08%-7.92B | -3.62%-2B | -3.36%-2B | -3.36%-2B | -10.58%-1.91B | -11.42%-7.53B | -11.16%-1.93B | -11.39%-1.94B | -10.76%-1.94B | -12.49%-1.73B |
| Net other financing activities | 107.58%264M | 319.21%2.66B | 25.99%-1.86B | -35.24%-1.28B | -37.39%740M | -45.15%-3.49B | 54.47%-1.21B | -3.29%-2.51B | 28.19%-945M | -70.51%1.18B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -231.55%-11.64B | 87.64%-1.03B | -25.40%-2.77B | -564.46%-7.95B | -98.80%99M | 69.54%-3.51B | -16.57%-8.34B | 68.96%-2.21B | 88.56%-1.2B | -37.60%8.23B |
| Net cash flow | ||||||||||
| Beginning cash position | -0.45%25.31B | -16.02%27.21B | 8.79%28.6B | 8.11%30.72B | -0.45%25.31B | 8.83%25.43B | -16.74%32.4B | -37.13%26.29B | -32.21%28.41B | 8.83%25.43B |
| Current changes in cash | -483.03%-632M | 64.27%-2.53B | -122.63%-1.38B | -17.89%-2.2B | 80.59%5.48B | -91.60%165M | 47.61%-7.09B | 314.33%6.09B | -1,104.52%-1.87B | -83.59%3.04B |
| Effect of exchange rate changes | 165.57%40M | 148.39%15M | -128.57%-4M | 250.00%14M | 131.25%15M | -162.89%-61M | -164.58%-31M | 124.56%14M | -92.73%4M | -194.12%-48M |
| Cash adjustments other than cash changes | -62.10%-355M | -1,031.43%-326M | -136.36%-4M | 124.91%66M | ---91M | ---219M | --35M | --11M | ---265M | --0 |
| End cash Position | -3.74%24.37B | -3.74%24.37B | -16.02%27.21B | 8.79%28.6B | 8.11%30.72B | -0.45%25.31B | -0.45%25.31B | -16.74%32.4B | -37.13%26.29B | -32.21%28.41B |
| Free cash from | -22.36%16.08B | -89.02%160M | -60.98%5.06B | 6.94%6.3B | 1,036.66%4.56B | -19.38%20.71B | 123.68%1.46B | 113.62%12.95B | -42.24%5.89B | -97.42%401M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm